Orthotopic brain tumor models derived from glioblastoma stem-like cells

Katharina M Eyme1, Alessandro Sammarco2, Christian E Badr3

  • 1Department of Neurology, Massachusetts General Hospital, Boston, MA, United States; Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.

Insights

Developing patient-derived xenograft mouse models is crucial for glioblastoma (GBM) research. These models help study the tumor microenvironment and test new therapies for this lethal brain cancer.

Area of Science:

  • Neuro-oncology
  • Cancer Research
  • Animal Models

Background:

  • Glioblastoma (GBM) is an aggressive, incurable primary brain tumor.
  • Effective therapeutic strategies for GBM are urgently needed.
  • Patient-derived xenograft (PDX) mouse models are valuable for GBM research.

Purpose of the Study:

  • To provide detailed methodology for establishing orthotopic glioblastoma mouse models.
  • To guide researchers in creating reliable models for studying GBM.
  • To facilitate preclinical testing of novel GBM therapeutics.

Main Methods:

  • Enrichment and expansion of glioma stem cells from surgical specimens.
  • Stereotactic injection of glioma stem cells into the brains of immunocompromised mice.
  • Monitoring tumor growth and progression in the orthotopic model.

Main Results:

  • Successful generation of orthotopic brain tumor models using patient-derived glioma stem cells.
  • Demonstrated utility of these models for studying the tumor microenvironment.
  • Established a reproducible method for preclinical therapeutic evaluation.

Conclusions:

  • Orthotopic patient-derived xenograft mouse models are essential tools for glioblastoma research.
  • These models enable comprehensive studies of the tumor microenvironment and therapeutic responses.
  • The detailed methodology facilitates the development of effective GBM treatments.

Related Concept Videos